Gene Query: DCBLD1

Dataset Description Geneva Score
IL-33 activates tumor stroma to promote intestinal polyposis 70.23
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 62.13
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 57.4
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 57.4
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 52.41
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 51.61
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 49.26
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 46.45
Differential analysis of gene regulation at transcript resolution by RNA-Seq 46.45
Statins modulate endothelial transcriptional profile by inhibiting EZH2 38.35
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 36.92
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 35.09
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 31.11
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 31.03
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 31.02
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 31.02
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 30.96
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 30.63
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 30.37
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 30.17
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 29.71
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 28.71
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 28.25
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 28.13
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 28.13
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 27.52
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 27.07
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 26.92
BI Human Reference Epigenome Mapping Project 24.85
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 24.82
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 23.85
Regionally specified human pluripotent stem cell-derived astrocytes 23.54
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 23.27
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 22.68
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 21.81
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 21.64
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 21.45
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 21.32
A sister of NANOG regulates genes expressed in pre-implantation human development 21.14
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 21.12
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 20.91
TGF-β promotes genomic instability after loss of RUNX3 20.83
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 20.05
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 19.25
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 18.61
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 18.58
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 18.31
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 18.18
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 18.11
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 18.02
Nutritional control of protein translation 18.0
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 17.86
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 17.7
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 17.49
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 17.4
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 17.4
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 17.29
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 17.06
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 16.82
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 16.64
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 16.6
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 16.36
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 16.28
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 16.17
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 16.16
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 15.8
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 15.74
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 15.53
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 15.53
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 15.48
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 15.48
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 14.79
A549 cells and MSR-A549 cells 14.79
Toxoplasma gondii infection of human retinal pigment epithelial cells 14.64
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 14.64
STRIPAK directs PP2A activity to promote oncogenic transformation 14.6
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 14.25
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 14.09
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 13.97
Differential gene expression of human melanoma cells [RNA-seq] 13.97
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 13.5
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 13.48
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 13.43
Gene expression in PANC1 cells treated with Rakicidin 13.06
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 13.04
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 13.04
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 12.96
Gene expression profiling of human and murine in vitro muscle differentiation 12.91
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 12.91
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 12.9
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 12.87
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 12.77
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 12.72
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 12.72
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 12.69
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 12.69
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 12.69
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 12.63
Fbxo32 mediated gene expression program underlies EMT and metastasis 12.56
The cohesin complex prevents Myc-induced replication stress 12.47
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 12.42
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 12.33
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 12.08
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 12.08
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 12.03
iPSC-Derived Cholangiocytes 11.84
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 11.83
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 11.62
RNA-seq analysis to identify the genes regulated by p53-SET interplay 11.62
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 11.5
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 11.5
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 11.38
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 11.38
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 11.24
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 11.21
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 11.16
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 11.15
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 11.15
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 11.04
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 10.99
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 10.96
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 10.93
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 10.91
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 10.91
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 10.82
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 10.74
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 10.65
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 10.56
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 10.47
RNA-seq of shEZH2 cells 10.46
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 10.43
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 10.3
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 10.26
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 10.25
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 10.2
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 10.14
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 10.14
Oncogenic MYC induces a dependency on the spliceosome in human cancer 10.09
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 10.05
PGE2 mediated gene expression changes in human cervical stromal cells 10.03
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 9.99
IRF2 is a master regulator of human keratinocyte stem cell fate 9.99
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 9.87
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 9.87
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 9.87
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 9.87
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 9.84
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 9.82
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 9.8
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 9.76
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 9.76
DJ-1 is dispensable for human stem cell homeostasis 9.74
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 9.72
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 9.72
Capturing the Interactome of Newly Transcribed RNA 9.69
Capturing the Interactome of Newly Transcribed RNA (RICK) 9.69
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 9.69
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 9.59
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 9.46
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 9.46
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 9.46
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 9.46
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 9.41
Differential Gene Expression between MCF10A and MCF7 cells 9.39
Exploring ILF2 regulatory genes by next-generation sequencing 9.31
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 9.3
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 9.13
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 9.11
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 9.1
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 9.09
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 9.04
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 9.04
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 8.99
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 8.96
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 8.95
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 8.94
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 8.94
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 8.93
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 8.87
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 8.85
FOXP2's impact on the primate transcriptome 8.8
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 8.73
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 8.72
RNA-seq of human aneuploid cell lines with Trisomy 21 8.71
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 8.67
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 8.67
Effect of mitochondria deficiency on senescence-associated gene expression 8.65
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 8.64
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 8.6
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 8.6
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 8.6
Ectoderm specification of H1 human embryonic stem cells 8.55
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 8.51
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 8.5
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 8.47
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 8.47
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 8.43
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 8.41
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 8.4
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 8.32
RNA-Seq from early time points in the kidney differentiation protocol 8.32
RNA-sequencing in immortalized human mammary epithelial cells 8.27
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 8.27
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 8.27
CSL RNA-Seq on HKC and SCC cell lines 8.22
CSL 8.22
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 8.21
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.14
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 8.04
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 7.98
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 7.98
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 7.95
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 7.95
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 7.94
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 7.92
RNA-seq analysis of control and Myc-induced U2OS cells 7.89
RNA-seq in transgenic cells 7.88
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 7.88
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 7.86
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 7.78
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 7.75
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 7.75
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 7.74
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 7.74
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 7.71
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 7.71
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 7.69
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 7.66
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 7.63
High level DNA repair gene expression in human ES cells 7.62
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 7.6
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 7.59
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 7.52
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 7.52
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 7.48
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 7.46
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 7.46
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 7.38
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 7.27
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 7.26
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 7.25
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 7.15
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 7.13
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 7.11
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 7.1
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 7.1
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 7.08
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 7.07
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 7.05
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 7.01
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 6.97
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 6.97
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 6.97
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 6.97
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 6.94
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 6.93
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 6.91
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 6.86
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 6.86
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 6.85
Chromatin landscape of human visceral and subcutaneous adipocytes 6.82
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 6.81
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 6.81
High-Throughput Kinetic Analysis of Fractional Killing 6.79
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 6.76
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 6.7
Investigation about fibroblasts of different origins in culture 6.66
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 6.66
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 6.61
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 6.55
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 6.55
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 6.53
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.53
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 6.51
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.49
A549 cell transcriptome responses to infection with H7N9 influenza virus 6.48
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 6.47
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 6.47
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 6.47
SLIGRL-induced gene expression changes in NHEK cells 6.42
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 6.42
Functional role of SLIT2 and ROBO1 in trophoblasts 6.4
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 6.38
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 6.38
Real-time observation of light-controlled transcription in living cells 6.31
Silencing SPIB in attached and floating state of H1703 lung cancer cells 6.25
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 6.23
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 6.23
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 6.22
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 6.18
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 6.17
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 6.13
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 6.08
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 6.05
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 6.05
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  6.0
A prostate cancer chromatin interaction map 6.0
Differetially expressed genes after hTR overexpression in U2OS cells 5.97
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 5.93
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 5.91
Transcriptome analyses of human pancreatic islets and pseudoislets 5.91
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 5.9
RNA-seq in endometrial stromal tumors 5.87
The effect of Abl kinases on non-small cell carcinoma global transcriptome 5.85
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 5.82
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 5.8
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 5.8
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 5.75
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 5.75
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 5.71
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 5.7
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 5.7
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.69
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.69
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 5.68
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 5.65
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 5.64
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 5.62
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 5.6
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 5.6
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 5.59
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 5.55
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 5.54
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 5.54
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 5.54
Fusion discovery in breast cancer cell line 5.46
Identification of the role of polydom in neurofibromas 5.42
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 5.4
Expression profiling of converted and control dermal BJ fibroblasts 5.4
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 5.33
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 5.29
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 5.29
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 5.19
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 5.15
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 5.15
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 5.15
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 5.1
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 5.01
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 5.01
hTERT promotes cell adhesion and migration independent of telomerase activity 5.0
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 5.0
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 4.97
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.94
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 4.89
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 4.88
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 4.87
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 4.86
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 4.85
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 4.85
TFAP2C signalling in human fibroblasts 4.85
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 4.83
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 4.83
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 4.82
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 4.7
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 4.69
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 4.6
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 4.6
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 4.52
4sU-seq of HFF exposed to salt and heat stress 4.5
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 4.45
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 4.37
JunB control of keratinocyte-mediated inflammation [RNA-seq] 4.37
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 4.36
RNA-Seq of Breast and Ovarian Cancer Cell Lines 4.33
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 4.32
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 4.32
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 4.31
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 4.27
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 4.27
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 4.27
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 4.25
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 4.21
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 4.21
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 4.2
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  4.11
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 4.09
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 4.09
Identification of differentially expressed genes between senescence and senescence bypass cells 4.09
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 4.04
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 4.0
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 3.98
Selective expression of long non-coding RNAs in a breast cancer cell progression model 3.94
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.75
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 3.68
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 3.68
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 3.63
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.57
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 3.56
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 3.56
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.54
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 3.53
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.48
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 3.48
Redifferentiation of expanded human islet β cells by inhibition of ARX 3.47
RNA-seq analysis upon ARID1B overexpression 3.4
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 3.39
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 3.25
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 3.22
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 3.22
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 3.13
mRNA sequencing of oropharyngeal cancer cell lines 3.08
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.07
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 3.05
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 3.05
CDK12 mediated transcriptional regulation in U2OS cells 3.03
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.02
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.9
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.82
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.8
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 2.69
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.69
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 2.62
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 2.58
Dynamic reorganization of nuclear architecture during human cardiogenesis 2.58
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 2.55
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 2.54
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 2.54
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 2.51
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 2.51
Nucleoporin-mediated regulation of cell identity genes 2.5
Analysis of transcriptional regulation by Myt1 and Myt1l 2.48
HBEC-shp53-PCHD7 2.42
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 2.35
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 2.25
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 2.19
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 2.11
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.06
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 2.0
Zika virus infection reprograms global transcription of host cells to allow sustained infection 1.99
RNA-sequencing of healthy human skeletal myocytes 1.93
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 1.9
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 1.9
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 1.9
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.9
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 1.82
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 1.74
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 1.73
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 1.71
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 1.7
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.66
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.66
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 1.64
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 1.64
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 1.61
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.57
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 1.54
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 1.51
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 1.5
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.48
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.47
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 1.43
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.4
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.36
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.34
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 1.33
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 1.32
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 1.3
Investigate A2M treatment on human prostate cancer and mouse liver 1.28
Investigate A2M treatment on human prostate cancer xenograft in mice 1.28
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 1.27
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 1.17
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 1.15
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.09
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 1.04
Gene expression analysis in response to hypoxic pathway inhibition 0.99
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.98
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.94
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.94
Gene expression profile of CRC-derived HILEC 0.92
RNA sequencing of human mammary epithelial cells 0.91
EGR1-controlled transcriptome of T HESCs 0.86
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 0.77
hNSCs siRNA NOVA2 0.74
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.72
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.7
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.69
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.69
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 0.69
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 0.64
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 0.64
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 0.63
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 0.61
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.58
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.57
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.52
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 0.42
NKX2.2 0.42
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 0.42
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.41
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.41
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 0.29
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 0.29
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.26
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 0.23
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 0.21
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.21
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.21
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 0.14
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.14
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation